Morningstar
•
May 01, 2026
Stryker Corporation: Stryker Earnings: Cyberattack Weighs on First Quarter, but Demand Hasn't Faltered
Summary
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the le
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: ResMed Inc.
May 01, 2026
•
RMD
Analyst Report: Zoetis Inc.
Apr 30, 2026
•
ZTS
Analyst Report: Illinois Tool Works Inc.
Apr 30, 2026
•
ITW
Analyst Report: Thermo Fisher Scientific Inc
Apr 30, 2026
•
TMO
Market Update: NDAQ, HON, IEX, INCY, OMC, TMUS, TMO, BKR
Apr 30, 2026
•
TMUS, NDAQ, OMC, HON, TMO, BKR, INCY, IEX
Analyst Profile
Debbie S. Wang
Senior Equity Analyst
Debbie Wang is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers the medical-device industry. Previously, she was an associate director of equity analysis for Morningstar, leading the healthcare team.Before joining Morningstar in 2002, Wang was a vice president and senior brand strategist for Leo Burnett. During her tenure at Leo Burnett, she led brand strategy on a variety of accounts, including Allstate, Amoco, McDonald/s, Heinz, Smucker’s, Pepto-Bismol, and Celebrex.Wang holds a bachelor’s degree in anthropology from Colgate University and a master’s degree in business administration from the University of Chicago Booth School of Business.
